Aurora Cannabis Inc (NYSE:ACB) Expected to Post Earnings of -$0.05 Per Share

Wall Street analysts expect Aurora Cannabis Inc (NYSE:ACB) to post ($0.05) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Aurora Cannabis’ earnings. Aurora Cannabis reported earnings of ($0.08) per share during the same quarter last year, which would suggest a positive year over year growth rate of 37.5%. The business is scheduled to issue its next earnings results on Tuesday, May 12th.

On average, analysts expect that Aurora Cannabis will report full year earnings of ($0.26) per share for the current financial year, with EPS estimates ranging from ($0.74) to ($0.14). For the next financial year, analysts forecast that the firm will report earnings of ($0.13) per share, with EPS estimates ranging from ($0.20) to ($0.06). Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that follow Aurora Cannabis.

Aurora Cannabis (NYSE:ACB) last posted its quarterly earnings data on Thursday, November 14th. The company reported $0.01 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.03) by $0.04. Aurora Cannabis had a negative net margin of 463.58% and a negative return on equity of 7.95%. The company had revenue of $57.02 million during the quarter, compared to the consensus estimate of $72.82 million.

A number of research analysts have recently commented on the stock. Compass Point dropped their price objective on shares of Aurora Cannabis from $5.00 to $2.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Bank of America downgraded shares of Aurora Cannabis from a “neutral” rating to an “underperform” rating and set a $1.00 price objective for the company. in a research note on Friday, January 10th. Canaccord Genuity reaffirmed a “hold” rating and set a $2.25 price objective on shares of Aurora Cannabis in a research note on Friday. CIBC reaffirmed a “hold” rating and set a $2.50 price objective on shares of Aurora Cannabis in a research note on Monday, February 10th. Finally, Pi Financial downgraded shares of Aurora Cannabis to a “hold” rating and set a $2.00 price objective for the company. in a research note on Friday, February 7th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating to the company. Aurora Cannabis presently has a consensus rating of “Hold” and an average price target of $3.65.

NYSE ACB opened at $1.58 on Wednesday. Aurora Cannabis has a 12 month low of $1.43 and a 12 month high of $10.32. The company has a 50-day moving average of $1.90 and a 200-day moving average of $3.67. The company has a quick ratio of 0.83, a current ratio of 1.27 and a debt-to-equity ratio of 0.12.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Global Retirement Partners LLC boosted its holdings in Aurora Cannabis by 90.1% in the 4th quarter. Global Retirement Partners LLC now owns 11,540 shares of the company’s stock worth $25,000 after acquiring an additional 5,470 shares during the period. Paradigm Financial Partners LLC purchased a new position in Aurora Cannabis in the 4th quarter worth approximately $25,000. PBMares Wealth Management LLC purchased a new position in Aurora Cannabis in the 4th quarter worth approximately $26,000. King Wealth purchased a new position in Aurora Cannabis in the 4th quarter worth approximately $26,000. Finally, Sandy Spring Bank boosted its holdings in Aurora Cannabis by 210.0% in the 3rd quarter. Sandy Spring Bank now owns 6,200 shares of the company’s stock worth $27,000 after acquiring an additional 4,200 shares during the period. 8.36% of the stock is owned by hedge funds and other institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Recommended Story: What does the Producer Price Index (PPI) tell investors?

Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.